PRCHD Historical Information
Planning for the Partnerships to Reduce Cancer Health Disparities (PRCHD) program began in 1999 with discussions with the National Institute of General Medicine Sciences, the National Center for Research Resources, and the NIH Office of Minority Health to seek broad support from these NIH Institutes for this novel concept of creating equal and mutually beneficial partnerships between institutions serving racial/ethnic and/or underserved communities with cancer health disparities and NCI-designated Cancer Centers (or group of centers). Later, we sought and affirmed interest for this concept from the potential applicant institutions, the Minority Serving Institutions, and the Cancer Centers, as they expressed strong and enthusiastic support.
In 2000, the NCI Executive Committee (EC) and Board of Scientific Advisers (BSA) approved the PRCHD program for 3 years. The PRCHD began funding of new applications in 2001. The total investment into the U54 program from 2001 to 2007 was $73,519,088.
After 3 years of funding, NCI evaluated the program to determine if its goals were being achieved. During that year, the RFAs were not reissued and no new partnerships were funded. Based on demonstrated progress, NCI decided to continue the program in 2005 and recommended that reissuance be sought annually.
Each partnership typically consists of two grants, submitted separately and reviewed together, that are complementary and reflect mutual benefits based on the strengths of the institution serving racial/ethnic and/or underserved communities with cancer health disparities and the CC. Some institutions, however, have formed triad partnerships, such as the Morehouse School of Medicine, Tuskegee University, and University of Alabama at Birmingham Cancer Center.
To date, the PRCHD program supports seven U54 and ten U56 partnerships.